Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No study data, eligibility criteria, or outcomes were altered.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing the previous v3.4.0 label.SummaryDifference0.1%

- Check47 days agoChange DetectedMinor UI and documentation labeling updates on the study page (e.g., Show glossary addition and QC-related label changes such as ‘Last Update Submitted that Met QC Criteria’ and capitalization adjustments). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedLocations section added with Illinois; Illinois Locations removed. HHS Vulnerability Disclosure link removed and revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.